BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Cue Biopharma
CUE
$128M
| $24.8K | ﹤0.01% |
98
+29
| +42% | +$6.97K |
|
3727
Bassett Furniture
BSET
$171M
| $24.8K | ﹤0.01% |
1,621
-65
| -4% | -$858 |
|
|
AKTS
3728
DELISTED
Akoustis Technologies Inc
AKTS
| $24.7K | ﹤0.01% |
3,193
+3,081
| +2,751% | +$20.2K |
|
3729
LG Display
LPL
$3.46B
| $24.7K | ﹤0.01% |
4,155
| – | – |
|
|
JAX
3730
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $24.7K | ﹤0.01% |
2,109
+53
| +3% | +$599 |
|
|
PBIP
3731
DELISTED
Prudential Bancorp, Inc.
PBIP
| $24.7K | ﹤0.01% |
1,450
+15
| +1% | +$258 |
|
3732
BeyondSpring
BYSI
$32.5M
| $24.6K | ﹤0.01% |
1,361
+1,309
| +2,517% | +$23.4K |
|
3733
Ohio Valley Banc Corp
OVBC
$211M
| $24.6K | ﹤0.01% |
675
+9
| +1% | +$315 |
|
|
CLPR
3734
Clipper Realty
CLPR
$50.9M
| $24.6K | ﹤0.01% |
2,414
+702
| +41% | +$7.68K |
|
3735
Evolution Petroleum
EPM
$134M
| $24.5K | ﹤0.01% |
4,195
+1,075
| +34% | +$6.57K |
|
|
BRT
3736
BRT Apartments
BRT
$268M
| $24.4K | ﹤0.01% |
1,672
+25
| +2% | +$350 |
|
|
IIN
3737
DELISTED
IntriCon Corporation
IIN
| $24.4K | ﹤0.01% |
1,254
+374
| +43% | +$7.23K |
|
|
OMP
3738
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
| $24.2K | ﹤0.01% |
1,517
-1,111
| -42% | -$20.2K |
|
3739
Cytosorbents Corp
CTSO
$23.3M
| $24.2K | ﹤0.01% |
4,816
+1,424
| +42% | +$8.28K |
|
3740
LifeVantage
LFVN
$82.1M
| $24.2K | ﹤0.01% |
1,765
+1,111
| +170% | +$13.5K |
|
|
LOVE
3741
LoveSac
LOVE
$253M
| $24K | ﹤0.01% |
1,285
+648
| +102% | +$13.6K |
|
|
TPCO
3742
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $23.9K | ﹤0.01% |
2,791
-1,294
| -32% | -$10.4K |
|
3743
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
| $23.8K | ﹤0.01% |
188
| – | – |
|
|
TNAV
3744
DELISTED
Telenav Inc.
TNAV
| $23.7K | ﹤0.01% |
4,968
+769
| +18% | +$6.47K |
|
3745
First Capital
FCAP
$220M
| $23.7K | ﹤0.01% |
410
+263
| +179% | +$14.6K |
|
|
BELFB
3746
Bel Fuse Inc Class B
BELFB
$4.25B
| $23.7K | ﹤0.01% |
1,574
+21
| +1% | +$291 |
|
3747
eGain
EGAN
$200M
| $23.7K | ﹤0.01% |
2,955
+957
| +48% | +$7.33K |
|
3748
Construction Partners
ROAD
$6.9B
| $23.6K | ﹤0.01% |
1,518
+1,100
| +263% | +$16.4K |
|
|
OPTN
3749
DELISTED
OptiNose
OPTN
| $23.6K | ﹤0.01% |
225
+81
| +56% | +$8.09K |
|
3750
Crinetics Pharmaceuticals
CRNX
$8.96B
| $23.6K | ﹤0.01% |
1,568
+546
| +53% | +$10.6K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.